Cetera Investment Advisers’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Buy
+6,655
New +$316K ﹤0.01% 4162
2026
Q1
Sell
-5,621
Closed -$518K 4878
2025
Q4
$518K Buy
+5,621
New +$538K ﹤0.01% 3408
2025
Q3
Sell
-17,003
Closed -$2.21M 4618
2025
Q2
$2.21M Sell
17,003
-1,948
-10% -$282K ﹤0.01% 1772
2025
Q1
$3.02M Buy
18,951
+2,231
+13% +$404K 0.01% 1439
2024
Q4
$3.1M Buy
16,720
+634
+4% +$123K 0.01% 1334
2024
Q3
$3.39M Sell
16,086
-1,426
-8% -$248K 0.01% 1237
2024
Q2
$2.34M Buy
17,512
+14,582
+498% +$2.76M 0.01% 1452
2024
Q1
$629K Buy
+2,930
New +$574K ﹤0.01% 2433
2023
Q3
Sell
-2,463
Closed -$800K 2251
2023
Q2
$800K Buy
+2,463
New +$704K 0.01% 1168

Other funds holding INSP

Cetera Investment Advisers's INSP Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 6,655 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #4162 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in INSP as recently as Q4 2025.

Cetera Investment Advisers first reported a position in INSP in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.39M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Cetera Investment Advisers held 6,655 shares of Inspire Medical Systems worth $297K as of Q2 2026.
  • Inspire Medical Systems was a new Cetera Investment Advisers position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4162 holding.
  • Cetera Investment Advisers first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Inspire Medical Systems position peaked at $3.39M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.